Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria.

Journal: Asia Oceania journal of nuclear medicine & biology
Published Date: Jan 1, 2015

Abstract

OBJECTIVES: Post-treatment evaluations by CT/MRI (based on the International Working Group/Cotswolds meeting guidelines) and PET (based on Revised Response Criteria), were examined in terms of progression-free survival (PFS) in patients with malignant lymphoma (ML).

Authors

  • Kayako Isohashi
    Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Mitsuaki Tatsumi
    Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hiroki Kato
    Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kentaro Fukushima
    Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tetsuo Maeda
    Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tadashi Watabe
    Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Eku Shimosegawa
    Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
  • Yuzuru Kanakura
    Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Jun Hatazawa
    Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka Suita city, Osaka, Japan. hatazawa@tracer.med.osaka-u.ac.jp.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals